DatasetName,BAG6_S(100) BAG6_S(1062) BAG6_S(1075) BAG6_S(1081) BAG6_S(1117) BAG6_S(113) BAG6_S(96) BAG6_S(964) BAG6_S(973) BAG6_S(984) BAG6_S(985) BAG6_T(1074) BAG6_T(1080) BAG6_T(972) BAG6_Y(1110) BAG6_Y(1116),BAG6_C(350) BAG6_S(1003) BAG6_S(1015) BAG6_S(104) BAG6_S(1084) BAG6_S(11) BAG6_S(1109) BAG6_S(1111) BAG6_S(26) BAG6_S(958) BAG6_S(967) BAG6_S(969) BAG6_S(994) BAG6_T(1083) BAG6_T(344) BAG6_T(350),BAG6_S(106) BAG6_S(1103) BAG6_S(1147) BAG6_S(23) BAG6_S(753) BAG6_S(99) BAG6_T(1053)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,0.5072680945108164,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.5933757732539783,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.6042494838060476,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,0.6025362818112757,,
ZX2022_Control Replicate 2,0.5869900436049752,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,0.5160370652084554,0.40223349191703445
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.5999117225589768,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.597398403952617,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,0.5979615571039936,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,0.5175984007430371,0.39263530843662603
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5855961480639593,0.5157694216315813,
WZ2023_Pu_010_30min,0.625493992803246,0.5125470303534951,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,0.5133294826445856,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.6179676376518326,,
RB2022_8_RecoveryEndurance,,0.49715350995129715,
KBE2022_Log2_Ex_14_U,0.5856290702099515,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.5937939753602592,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,0.5083346275795599,0.3878572508004927
PG2020_Intensity 8h_C,0.5856317365211069,,
AH2018_SILAC_MR_2_N,0.6151992291369108,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5617120698298327,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.5798056016155522,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.6080106615358667,0.4883926821401095,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,0.5074001034579722,0.39769388063888356
GF2025_P6_Sph,0.5813422134091103,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5860104479962338,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.6273321489299264,0.5117377156711933,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,0.5979477685517829,,
KBE2022_Log2_Ex_34_U,0.5997875322584542,,
WZ2023_Pu_005_10min,0.6256397393885721,0.5110390080068845,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.6023397073834521,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.6262224798441597,0.5116077843575825,
AH2018_SILAC_MR_2_X,0.620081163593664,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,0.5990701477204946,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.578548512846373,0.5136682772195716,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,0.39910241792406315
EJN2021_3_Rest_Basal,0.5961456460322859,0.5205990138434539,
CR2017_Ratio Replicate 1.3,0.5986622551986163,0.5126752712850368,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.6051362145892594,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.6009712767528236,,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,0.6222921841486827,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5736817480318087,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.627243027472875,0.5104968922004296,
CK2022_11 40-1,0.6013818928956763,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.6021265182494161,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.6123936458215222,,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,0.6246882099660369,0.5117425771287167,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.586472735721005,0.5113403555120739,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.6257187831030298,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.5927036304303603,,
CK2022_1 200-1,0.6057092411220948,0.5109596658453375,
PG2020_Intensity Mock_10h_D,0.571284275960709,,
SR2019_MCF10A_Biol_repl_2,0.586395172762359,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5910838105999722,0.5165670760136641,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,0.6031732880544654,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5894310298630061,0.5125263619944564,
PG2020_Intensity 2h_C,0.5746441985133334,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.584404239245966,,
KBE2022_Log2_Ex_8_T,0.584935611018287,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,0.6019679164711808,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.6199265294768835,,
CK2022_3 40-1,0.5998476228892884,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.5823131675835538,,
HH2022_Reporter intensity 8,,0.511968761198442,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.5978620089129087,,
EJN2021_5_Rest_Basal,0.5949014571188157,0.5149238099945799,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.6039429524172807,,
YA2020_Reporter_intensity_Normal_No.1,0.5855679763160385,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,0.5145619738466896,0.38912424541127477
CR2017_Ratio Replicate 3,0.5965129301813669,0.5129893919767589,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.5841607470496251,0.5069451142294252,0.40466603594338757
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.5848012133555491,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,0.5172566684176142,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,0.5986037036675431,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.6261066776759939,0.5117302511735797,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.6004481794721016,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.591738213157378,,
KS2014_Intensity N3,0.6106168874010419,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,0.5129435705755834,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.6041441780683542,,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,0.5948411970967856,0.5299799213150633,0.40581542704123946
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,0.5161228864887615,
KS2014_Intensity E15_2,0.6126135941682105,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.5670164528473979,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,0.5827931927525738,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.6053997105607941,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5711840822291204,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.6128121131847588,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5801364432020875,,0.3796254070153434
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,0.598172037302573,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5858667457742345,0.5163615944343253,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.5804893824072791,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5031506359238481,0.38276813900960044
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.5835144631056837,,
AH2018_SILAC_IT_3_X,0.6047639269981103,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.5822278052741214,,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,0.5159834233843179,
SR2019_HCC1954_Biol_repl_2,0.5849352882447341,,
CK2022_14 40-1,0.5991881574213416,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,0.5782853222639313,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.6175354270603635,,
DL2023_control-1,0.5976547915869664,,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.6085183875324566,,
EJN2021_4_Rest_Ins,0.5964567218385171,0.5162882342659213,
RN2012_H05,0.6039536658231535,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5935726163591528,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,0.5956558180690643,0.5209019299648479,
HH2022_Reporter intensity 3,,0.5128280512343498,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.6065623828788863,,
JW2021_After_3,0.6018509443704336,0.5114475468076164,
GF2025_P8_Sph,0.59286759471309,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.6005738013232914,,
CK2022_11 200-1,0.6007780144505002,0.5111462246113365,
CK2022_12 200-1,0.6007265702709547,0.5108594416840829,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.5143346183341915,
WZ2023_Su_010_20min,0.6253414834754851,0.5128940785829881,
AH2018_TMTMS2_2_N,0.5943908649064353,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.5983250118252985,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5213829056011808,0.3916037876549764
AH2018_TMTMS3_Pool,0.596114522470077,,
KS2014_Intensity N4,0.6178250568203719,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,0.5858536074143433,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.6080171163825578,0.5101343777842834,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,0.4043663034166355
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.5973266980864796,,
AST2020_anti-CD3+PDL2.2,0.5978888485229221,,
PG2020_Intensity Mock_10h_A,0.5717004543604616,,
JW2021_After_2,0.59795840273355,0.5171043286297335,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.5955907112269766,0.5190547085272431,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.5958829737973903,,
GF2025_P1_Adh,0.5747720201130713,,
GF2025_P1_Sph,0.5878847036403456,,
EJN2021_5_Ex_Basal,0.5951454106229093,0.5182595834357498,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.6215368286927604,0.5126032859243275,
CF2017_EOC 1,,0.501984770279725,
CK2022_3 200-1,0.606939910865273,0.5099194575753903,
AH2018_LFQ_IT_3_C,0.6025964129787101,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,0.5883561828615905,0.520199347739918,0.40161774380343057
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,0.6039407189194774,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.6035674650036141,,
RB2022_1_PostSprint,,0.5071904613488346,0.3956754064119549
CK2022_4 200-1,0.6068459496431906,0.5096965301546208,
JW2021_Before_2,0.5881188639685394,0.5027091794914326,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.5928050319835576,,
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.5980301870749763,0.5216468024107853,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.5781919962492741,0.5133435270331063,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.5949098586683645,,
CK2022_9 16-1,0.5932391488824074,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.6083725842974321,0.5120326545698747,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,0.5602936407109229,,
CK2022_16 16-1,0.5959751211659104,,
FS2019_db/db3,,,
CK2022_15 40-1,0.6013595078108241,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.6201710034204303,0.5122786768531353,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.5966933927518394,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.6020750037220104,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.598627905708069,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.5866026130565292,,
AH2018_LFQ_M_1_N,0.6252660629183519,,
KBE2022_Log2_Ex_27_U,0.5799213358620384,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.6042022852344608,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,0.5018265117407567,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.5823815979756678,,
YA2020_Reporter_intensity_Normal_No.4,0.5860759209863433,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.5641931765584268,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.5963423185617122,,
RN2012_L13,0.5916229933018321,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.5828343707114987,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.6019432918722407,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.5939591220489886,,
HH2022_Reporter intensity 6,,0.5106792323208948,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,0.5548242046131189,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.5964424513173424,,
GF2025_P3_Adh,0.5850877197422347,,
SR2019_JIMT1_Biol_repl_2,0.6011182924034828,0.5116430301901713,
AH2018_TMTMS2_1_C,0.5951656426315082,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5777136854559202,,
KBE2022_Log2_Ex_19_U,0.5876467329820325,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.581782322063244,0.5110105926084801,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.5910433517864709,,
AST2020_Control,0.5981098454568006,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5927100674483436,0.5158047000009853,0.35547230509525324
RB2022_7_RecoverySprint,0.5943548596067298,,
YA2020_Reporter_intensity_Normal_No.3,0.5917295999602497,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.6158613987704517,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.6179595341877454,,
HH2022_Reporter intensity 1,,0.5091052632940222,
HH2022_Reporter intensity 2,,0.5094991372468481,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.5820366014818159,,
SR2019_MCF7_Biol_repl_1,0.587443203148981,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5944450969811835,0.48195360685510535,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,0.5138401709462656,
CR2017_Ratio Replicate 2,0.5863259692310304,0.5100834097390972,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5835736171707018,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.5942646155996523,,
KBE2022_Log2_Ex_9_U,0.5914431169392655,,
AH2018_SILAC_M_3_N,0.604148014387623,,
KBE2022_Log2_Ex_13_T,0.5845122895013708,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,0.5855384157190081,,
PG2020_Intensity Mock_10h_C,0.5792533279510137,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,0.6012467270076663,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.5597589907765496,,
RN2012_L12,0.5979954271170017,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.6047274867336792,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,,0.5192285485217123,0.39295001690706943
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.6044267489682956,,
RB2022_7_RecoveryEndurance,,,0.40698441184671236
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.5956891383335944,0.5154158671183934,
TM2022_S2.12h.B,,,
RN2012_L15,0.5987555319498207,0.5155343489833114,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,0.5639297272217157,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.5969520018518183,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.6021837570324496,,
RB2022_1_PreSprint,,,0.3996477355924384
HS2024_4_I_N1,,,
CK2022_7 200-1,0.6075610845228925,0.5115552895711359,
CK2022_5 200-1,0.6082017486845889,0.5118714147701765,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.6165245718031424,,
AH2018_SILAC_MR_1_X,0.6163892114992817,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.5962026859622006,,
AH2018_SILAC_3_C,0.6047952876351876,,
EJN2021_5_Rest_Ins,0.5949967720453454,0.5173540638056596,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,0.592009348191956,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,0.5884346534616577,,
EJN2021_2_Ex_Ins,0.5953088738862451,0.5225686259099962,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.6226537143553182,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.5797559829579568,0.5092504033746554,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,0.5757942825497288,,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,0.6027101830070889,0.5125222701810651,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.5869256689011215,,
AH2018_SILAC_IT_2_N,0.6096068820910457,,
AH2018_SILAC_IT_1_X,0.6066531837367659,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,0.5791080122719192,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5893621427401907,,
WZ2023_Pe_025_20min,0.6189033378954207,0.5120249207828202,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.6176281211041149,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.5962360709778087,,
RN2012_H06,0.5958795440942993,0.5141687304612887,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.6304504793016836,,
SR2019_HCC1419_Biol_repl_4,0.5960842960824905,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,0.5703030538890653,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.5779810688641993,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.5817436313943777,0.513113545401674,
WZ2023_Su_025_10min,0.6278667478192185,0.5109392403793891,
AH2018_LFQ_IT_4_X,0.6050882623643276,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.588712110633805,0.508604921732388,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.6233854058376952,0.5120612084137369,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,0.5908182403981711,0.5155713488998758,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,0.5094177903151785,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.6099977861100582,0.49786676016770265,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.5988569410570164,0.5239531615863197,0.3865227363873301
KS2014_Intensity,0.6274130712779794,,0.38758887780879087
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.5549454242038756,,
LY2019_P7+,0.5856449177791307,,
EP2017_Untreated R#1 normalized log2 ratio,0.5809770361700359,0.496168863210671,
RN2012_L10,0.595484142316724,,
PG2020_Intensity 4h_C,0.5707198942121494,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5886711155342719,0.5159716728201996,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.5953403611664244,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.606217894276158,,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.5683252976031313,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5876319844965912,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.6087546342240182,0.5104714412365877,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5894792777432222,0.5148511969142447,
GF2025_P9_Sph,0.5975522440037645,,
CK2022_6 200-1,0.6082788100673666,0.5111998724055639,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.5925647138338609,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,0.5150318604115509,0.39904050404135377
SR2019_HCC1954_Biol_repl_1,0.5748259380820742,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,0.5895426576231813,,
PG2020_Intensity 2h_D,0.5716972236595314,,
EP2017_Untreated R#3 normalized log2 ratio,0.5936486082247338,0.5409957237251204,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.6082450724674191,0.5114368582370781,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.5822078801874555,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.6014806561083161,0.47740797896747483,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.6026547493331581,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.5889043824239986,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.5944596327227716,0.5151411872287232,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.6163583325901743,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,0.5118051743422644,
PG2020_Intensity CT_C,0.576177996504962,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.5716820024502562,,
EP2017_Untreated R#3 log2 ratio,0.5940296293967413,0.541743166874221,
RB2022_2_PostStrength,0.5796670264372229,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.5877452709569585,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,0.5032596144035917,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.566119678356795,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,0.5168412781245182,
CR2017_Ratio Replicate 2.3,0.5954548272518815,0.5115052956834454,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5943887311893713,,
YA2020_Reporter_intensity_Normal_No.2,0.5819027429570973,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,0.5262235448208354,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.6211902917521956,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.5864564801257398,,
CK2022_2 16-1,0.5938886277027906,,
RAM2015_Log2 B,0.5964707524888618,0.51936426764158,0.40598392894757057
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.5958668783986825,0.5195344607795631,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,0.5794283076221113,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,0.514423972078167,0.3914943065672584
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,0.6024221552511985,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,0.5481126099677832,,
WZ2023_Su_025_30min,0.6230711065468106,0.5118269432732356,
AH2018_LFQ_4_N,0.6198590790153822,,
CR2017_Ratio Replicate 1.2,0.5980477809755179,0.5142723088775347,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,0.5143396547958744,
AH2018_SILAC_M_1_X,0.6052949687439824,,
RB2022_7_PreEndurance,,0.5040385040838645,0.401287088504949
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,0.6021856897412221,,
LY2019_P6+,0.610854371906942,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.584260878752255,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,0.5190105792902596,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.5935318544009134,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,0.6121458176681871,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,0.501823499497253,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.5902125113843005,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.6232331427576501,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,0.5857860928109071,,
AH2018_LFQ_2_X,0.6181939626061542,,
PG2020_Intensity 2h_B,0.5714691569865037,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.5839139252658423,,
KS2014_Intensity E15_3,0.606185089080717,,
GF2025_P3_Sph,0.5965707907038027,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.6041901445917763,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.5097086042439567,0.4015798880799525
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.6093429720541921,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,0.5150973138317452,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.572647389437741,0.5068863694688684,
ZQ2022_N1,,,
LY2019_P6-,0.5881737138656545,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,0.5781895712787002,,
JW2015_Intensity pre2,,0.5129381096775513,0.3954179763848959
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5997066778603865,0.5130412470624419,
AH2018_LFQ_3_N,0.6194726440778661,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.5830542455470092,0.5113277907803206,
UK2020_UA_1,0.5795415314489447,,
KBE2022_Log2_Ex_13_U,0.5824779688030328,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,0.5069206368791533,0.3879289466025103
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.603539882188858,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,0.5782629358797187,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,0.5001223077509486,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.6248898534484127,0.5109204700952583,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,0.5833535018739774,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.6004936671219986,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.5937518893954369,,
PG2020_Intensity 10h_D,0.5763501408342258,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.5953570173457294,0.5179911161155383,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.5937479550276554,0.5196888180330601,
EP2017_Pervanadate R#3 log2 ratio,0.607944105040492,0.48829465231113167,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,0.5141019895851063,0.4171821296372328
AH2018_SILAC_MR_3_C,0.6176658959615299,,
AH2018_LFQ_M_4_C,0.6212681709233605,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,0.6011304724969502,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.600186713487001,,
CK2022_6 40-1,0.6058751569652291,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.5698229757011999,,
LY2019_P3-,0.5937075723708941,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.5944632033120179,0.5175609447201379,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.6291115130972804,0.5122490810285084,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.5953087261684906,0.5171857609222144,
AST2020_Control.1,0.5978411643075442,,
JW2015_Intensity cap1,,0.5169225421387649,
PG2020_Intensity CT_A,0.559674527160399,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.6287458769866552,0.5116687450659454,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.6029644838694219,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,0.5809478300928043,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.5941988984012161,,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.5958899543795572,,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,0.5102156197204979,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.6056752693410213,,
LY2019_P8+,0.594887862039131,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,0.5070767210235075,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.5236143695635928,0.4016667077093245
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.6151711533186217,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5723566624347621,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,0.5088090022160316,
LY2019_P2-,0.5500164388580139,,
AH2018_LFQ_IT_1_X,0.6051103703374109,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.5934634197285352,0.5362698288007214,0.4076068747344878
WZ2023_Pe_005_20min,0.6195487608569685,0.5126399001502243,
AST2020_Control.2,0.5984915875916057,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.6012879438684232,,
SR2019_MCF10A_Biol_repl_4,0.5802247772086924,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,0.5115441948310386,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5786830342010588,,
AH2018_TMTMS3_3_N,0.6009969568066386,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.619746495557687,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5888825181470042,0.5162499421904009,
KBE2022_Log2_Ex_36_T,0.5828814246469699,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.6292102531211401,0.511546680197484,
KS2014_Intensity C2,0.6087686661256474,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.5690481685143605,,
CK2022_9 200-1,0.6008658010200014,0.511134629044909,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.6015612422230527,0.5116704953741096,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,0.5597661979261126,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.5854231803324366,0.509260521000801,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.6113424200661057,,0.40486564051825397
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,0.5955227435776215,0.5182339027146416,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5725127579696103,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5812840543916643,0.4967548972526024,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.620514633741424,0.5123969289677007,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,0.6177861607364233,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.5789871632865023,0.5113580588515837,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.6168416848073361,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,0.5770231739990435,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.615678838531705,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.6047955438954922,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,0.5988622101435506,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.6277562748503525,0.5122588366135394,
KBE2022_Log2_Ex_29_U,0.5917706704106369,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.621888798422265,,
AH2018_LFQ_IT_4_N,0.6038900250122349,,
CK2022_15 200-1,0.6089356995018945,0.5120121496855499,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.5977747611020409,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.5821829809125588,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.6082706451873239,0.5126968647698228,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.6187120089190583,0.5121526799737218,
RN2012_H01,0.5985170865223992,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.5944254599202405,0.5206118882947453,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,0.589425420428588,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6099272209014147,0.4980191865305903,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.5829478395573778,,
KBE2022_Log2_Ex_44_U,0.5985037575974159,,
WZ2023_Pe_010_20min,0.6284418452328926,0.5120212014555569,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,0.5033952459259334,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.5158144859913559,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.6100048530330334,,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,0.6048781769120916,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.6029045234099533,,
AH2018_SILAC_M_2_X,0.6010570452351903,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5658406051378054,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.6141334796304259,0.5127415347612149,
PG2020_Intensity 6h_C,0.5761719007960787,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.6229701143574603,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.5960167259518243,,
CK2022_15 16-1,0.5965592703966106,,
CK2022_3 16-1,0.5925819963592521,,
LY2019_P4-,0.5948682395291275,,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.5852732878782232,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5783591792002457,,
CK2022_10 16-1,0.5916887990785075,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5018842012237006,0.40351777336375816
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.5776019820955214,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.5891632307482609,0.5141280697148577,
EJN2021_2_Ex_Basal,0.5953087261684906,0.5158760715128069,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,0.5156429705754033,
AR2021_L41 10 μM,,,
CF2017_EOC 2,,0.5160802828718064,
RB2022_6_PostEndurance,0.5908716096696276,,
AH2018_SILAC_1_N,0.604083325746839,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.5784291446963434,,
RB2022_7_PreSprint,,,0.3948481057838991
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.5927933106019311,,
ZX2022_CB treated Replicate 1,0.5849256346725018,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.5094239056233759,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.5939595599099221,,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.5941611994507692,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5860758960565914,,
KS2014_Intensity C4,0.6129057559963169,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5921715239514778,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.6169280542421588,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.5841406224406052,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,0.6052199219173078,,
WZ2023_Pu_025_10min,0.6230480176293897,0.511554769853607,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,0.5855007331185256,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,0.5071692221551816,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.6192894371390156,0.5129712848283757,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.6004952919225047,,
KS2014_Intensity C6,0.604384219755886,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.6006559352296806,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5885791532826419,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.6006569896002187,,
AH2018_SILAC_IT_2_C,0.606290295989958,,
CK2022_5 40-1,0.605759561900986,,
AH2018_LFQ_3_X,0.6242584794517069,,
UK2020_UA_3,0.5783664415907311,,
LY2019_P7-,0.5891278921784382,,
GF2025_P5_Adh,0.5798575013057684,,
RB2022_1_PostStrength,,,0.3953560116217771
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,0.5752761734041895,,
CR2017_Ratio Replicate 2.2,0.6033557347423815,0.5136174452925341,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.5935586809542125,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.5934497092647532,0.5125820103322947,
PG2020_Intensity CT_B,0.5787293513774001,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.6149841431633358,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,0.5882360379034682,0.5152874812162523,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.510751366170955,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.6146314901034772,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.6276008845192025,,
YA2020_Reporter_intensity_Cancer_No.4,0.581778706839001,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5865933270438968,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,0.5864490666321043,0.5104213659682709,
KBE2022_Log2_Ex_25_T,0.5953688601779831,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.5955216973176504,,
AST2020_anti-CD3+PDL2,0.598633889877525,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.5839845414075746,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.5092785777714566,
EP2017_Mitotic R#2 log2 ratio,0.5907081135318124,0.5159357132137163,
AH2018_TMTMS2_1_X,0.5948645572471937,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.5972654373473031,0.5178073652995554,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,0.5113193856802414,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,0.5083257782311739,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.6050767342435988,,
PG2020_Intensity 10h_B,0.5789340989355449,,
AH2018_TMTMS3_1_X,0.5946328103933669,,
CF2017_FTE 14,,0.5157421395010499,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,0.5474463534492175,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.5848523256827973,,
EP2017_Untreated R#2 normalized log2 ratio,0.5941082958064557,0.48147621693683673,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,0.5525302718670315,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.6014453514575466,0.47720958498330407,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
